Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lillicrap

Showing results (21-30 of 216) with videos related to

Pageof 22
Sort By:
Nature Medicine|October 9, 2012
A complex substitute: antibody therapy for hemophiliaDavid Lillicrap
Seminars in Thrombosis and Hemostasis|December 17, 2008
The role of molecular genetics in diagnosing von Willebrand diseasePaula James, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|January 16, 2019
Abstract thoughts of hemostasisDavid Lillicrap, James Morrissey
Seminars in Thrombosis and Hemostasis|August 13, 2019
Innovative Molecular Testing Strategies for Adjunctive Investigations in Hemostasis and ThrombosisElham Ghorbanpour, David Lillicrap
Human Molecular Genetics|July 24, 2019
Advances and challenges for hemophilia gene therapyPaul Batty, David Lillicrap
Hemasphere|February 19, 2021
Hemophilia Gene Therapy: Approaching the First Licensed ProductPaul Batty, David Lillicrap
Thrombosis Research|May 8, 2007
Von Willebrand: the scientist, the disease, the factor, and the treatmentErik Berntorp, David Lillicrap
Haematologica|January 7, 2026
Molecular genetic testing in von Willebrand disease: past, present, and beyondOmid Seidizadeh, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
Hemophilia A treatment innovation: factor VIII mimetic bispecific antibodies-generational enhancementDavid Lillicrap, Peter Lenting
Hamostaseologie|February 15, 2021
Functional Roles of the von Willebrand Factor PropeptideOrla Rawley, David Lillicrap
Pageof 22

Showing results (21-30 of 216) with videos related to

Sort By:
Pageof 22
Nature Medicine|October 9, 2012
A complex substitute: antibody therapy for hemophiliaDavid Lillicrap
Seminars in Thrombosis and Hemostasis|December 17, 2008
The role of molecular genetics in diagnosing von Willebrand diseasePaula James, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|January 16, 2019
Abstract thoughts of hemostasisDavid Lillicrap, James Morrissey
Seminars in Thrombosis and Hemostasis|August 13, 2019
Innovative Molecular Testing Strategies for Adjunctive Investigations in Hemostasis and ThrombosisElham Ghorbanpour, David Lillicrap
Human Molecular Genetics|July 24, 2019
Advances and challenges for hemophilia gene therapyPaul Batty, David Lillicrap
Hemasphere|February 19, 2021
Hemophilia Gene Therapy: Approaching the First Licensed ProductPaul Batty, David Lillicrap
Thrombosis Research|May 8, 2007
Von Willebrand: the scientist, the disease, the factor, and the treatmentErik Berntorp, David Lillicrap
Haematologica|January 7, 2026
Molecular genetic testing in von Willebrand disease: past, present, and beyondOmid Seidizadeh, David Lillicrap
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
Hemophilia A treatment innovation: factor VIII mimetic bispecific antibodies-generational enhancementDavid Lillicrap, Peter Lenting
Hamostaseologie|February 15, 2021
Functional Roles of the von Willebrand Factor PropeptideOrla Rawley, David Lillicrap
Pageof 22